Our Partners

The Uppsala region is very strong in research and innovation within both life- and materials science. Additive Manufacturing progress is closely related to R&D in materials science, and the combination of life- and materials science has enormous potential to result in a number of fruitful synergies. However, we see a great need for increased cooperation and knowledge sharing between fields and stakeholders in order to advance at a satisfactory pace, and this is the reason for the creation of this centre.

Currently, the AM4Life Competence Centre has 24 partners, which can be divided into three categories:

  • 17 industrial partners (including 8 Swedish SMEs (AddNorth, Additive Composite, BioLamina, Disruptive Pharma, Graphmatech, Medviso, Resorbable Devices, VBN Components), 5 larger companies (AFRY, Cytiva, Cellink (BICO group), Erasteel, Kanthal) and 2 companies located outside Sweden (Hydrumedical, Protugal and Poietis, France) and 2 Swedish research institutes: SWERIM and RISE)

  • 5 academic partners (3 national universities: KTH, SLU, UU; 2 international universities: University of Minho, Portugal and UPC Spain.

  • 2 public organizations (Region Uppsala including Uppsala University Hospital and the Swedish Medical Products Agency)

FULL LIST OF PARTNERS (updated in January 2024)

Additive Composite are using 3D-printing to enable new and innovative solutions for a variety of research and commercial applications. We create novel, special polymer composites for use with 3D-printing technology. The materials are well suited for demanding applications where properties such as neutron and x-ray shielding are needed. We provide expertise in the field of neutronics and polymer based radiation shielding, as well as the use of such materials in additive manufacturing. We design and manufacture materials as well as fabricated products according to your needs.

3D printing offers unique possibilities to test new materials and we want to be in the forefront in contributing to replacing the black carbon atom with the green one in all possible parts of society. We offer our customers a completely different responsivity and possibilities to customization and pioneering circularity in the industry for 3D filaments.

The world is facing a global crisis as the effects of climate change continue to worsen each day. Explore how AFRY is working with clients across many industry sectors on a range of decarbonisation initiatives.

Association for the Advancement of Tissue Engineering and Cell-Based Technologies & Therapies (A4Tec), created in 2007, is a non-profit scientific association whose mission is to promote the scientific and technological advancement of Human Tissue Engineering and Regenerative Medicine, the education of technical and scientific staff in the fields of Biomedicine and the dissemination of scientific research to the scientific community and civil society. A4TEC was created and is constituted by researchers and graduated students who develop scientific, clinical, or technical activities in the area of ​​Tissue Engineering and Regenerative Medicine, mainly at 3B’s Research Group (University of Minho).

BioLamina is a biotechnology company built on a scientific foundation with a legacy in matrix biology and cell culture-based research. We want to help scientists who have struggled for decades to culture embryonic stem cells, induced pluripotent stem cells, and other primary cells. By providing tools for efficient and easy culture, BioLamina aims to smooth the path towards safe and effective cell therapy. Whether your goal is to answer basic scientific questions, advance cell therapies, or make models for drug development, our products can help you in your journey. The power of our Biolaminin® substrates has been shown in numerous publications and they will continue to provide vital support for the stem cell community – from scientific concepts to clinical studies.

As the leading 3D bioprinting company, CELLINK is committed to providing the most advanced 3D bioprinting products, services and technologies needed to understand and master biology. We develop technologies that democratize 3D bioprinting – providing the leading researchers in the world the tools they need to create the future of health. Whether it is developing and utilizing alternatives to animal models, accelerating drug discovery, rethinking regenerative medicine or developing tissue engineered organs to treat diseases previously considered untreatable.

We’re bringing together a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service to help researchers and biopharma advance therapeutics at every stage from discovery to delivery. Our combined heritage dating back hundreds of years better positions us to serve our customers. Cytiva is part of Danaher, a global science and technology leader. Along with Danaher’s diagnostic and life sciences businesses, we accelerate the impact of innovation to help improve human health.

Disruptive Pharma is a pharmaceutical company utilizing its innovative MMC drug delivery technology to enable amorphous drug formulations. We aim to work with partners to turn their APIs into novel and commercially attractive drug products. Disruptive Pharma provides the MMC technology and expertise for solving drug delivery problems. The company’s MMC technology is based on particulate amorphous mesoporous magnesium carbonate which offers competitive advantages over other technologies.

Erasteel Kloster is a leading supplier of gas atomized metal powder and products based on metal powder. Our main products are bars in powder metal high speed steels for tools and components. Our activities in the center has been mainly focused on the use of our metal powder in AM printing. Erasteel has also been active in sharing knowledge of gas atomized metal powder among students and researchers in the center.

Graphmatech AB is a materials technology company that invents, develops and sells graphene-based materials. We are a proudly Swedish company made up of a diverse, international team spanning nine nationalities.

Hydrumedical was born in 2016 out of our CEO’s (Alexandre Barros) Ph.D. research project, where a clear need was identified by the medical community to reduce kidney stone post-surgery complications. Knowing how our Hydrustent product, a biodegradable ureteral stent, could impact the lives of so many patients as well as reduce treatment costs by approximately 60%, challenged us to continue the research in this field and that was the foundation on which the company was built. Based in Portugal, we started with a small team, and we have been growing since then. Soon we became a multi-award-winning company and along with the specialized team we were gathering, that gave us the lead to develop innovative medical devices in urology but also in stoma care, infection control, and Sports Medicine. In AM4Life center we leverage our competences in developing biodegradable medical devices and learning new competences around the bioprinting of metal-based biodegradable devices.

The department of Fibre and Polymer Technology is the largest academic institution on native and synthetic polymers in Sweden. The combination of the traditionally separate fields of natural and synthetic polymers is unique and the broad knowledge makes it possible to address several important issues such as future demands on a sustainable material use in society. Anna Finne Wistrands research, including many collaborations, have during the last years been devoted to understand how the polymer behaves in AM and how the process influences the polymer, define the surface characteristics of the printed samples and, for example, correlate that with biofilm formation and cell-material interaction. The motivation is to improve the overall usability of AM so that it becomes the first manufacturing choice in the future and also to transform polymer-based AM from a comparatively green fabrication process to a truly green technology.

The vision and mission for the Swedish Medical Products Agency  is to spread awareness  on regulatory science  to the members of the AM4Life Competence center and to gain authority prepardness  by following the scientific progress in the  field of additive manufacturing.

Medviso is a Swedish medical technology company with a mission to empower healthcare and researchers to make a difference. We design, develop, and manufacture post-processing software for medical image analysis in the space of additive manufacturing. We consistently develop with innovation in mind to bring the latest research to clinical practice. Within the center we bring knowledge in medical image analysis, regulatory expertise and experience in clinical practice around additive manufacturing.

Poietis is a biotechnology company ­specialized in the development and manufacturing of ­human tissues by 4D bioprinting. Since its ­inception in 2014 the company has been ­developing ­physiological models, particularly in partnership with the world’s leading ­pharmaceutical and cosmetic groups. ­Poietis markets Poieskin®, the first commercial ­bio-printed human tissue.

Region Uppsala exists to serve the people of Uppsala County. Our goal is to create conditions for good health and sustainability and development for everyone living and working here. Region Uppsala aims to promote health and improve the quality of life of the people who live in the conuty. You should feel safe in the knowledge that we provide equal health, medical and dental care services characterised by high quality, good accessibility and good treatment. We aim to create good opportunities for healthy, safe and sustainable living and working environments. Our resources should be used in the best possible manner, in a way that makes you feel involved.

Our mission is to strive for sustainable growth in Sweden by strengthening the competitiveness and capacity for renewal of Swedish industry, as well as promoting the innovative development of society as a whole.

The company Resorbable Devices AB is the owner of the patents of this medical device. The company also owns the registered trademark LigaTie®. New medical devices are developed to enable quicker, easier and safer surgery. This will reduce risk of complications and shorten time needed for recovery. Absorbable/resorbable medical devices are left in the body where after they are safely resorbed by the tissue. The innovative resorbable surgical products of the company are unique and protected by patent(s). Devices in development are intended for urology and orthopaedics. LigaTie® is initially intended for veterinary surgery and is clinically tested.

SLU is a leading international university providing research, education and environmental assessment within the sciences for sustainable life. Its principal sites are in Alnarp, Umeå and Uppsala, but activities are also conducted at research stations, experimental parks and educational establishments throughout Sweden. We bring people together who have different perspectives, but they all have a common goal: creating the best conditions for a sustainable, thriving and better world.

The metals research institute Swerim conducts needs-based industrial research and development concerning metals and their route from raw material to finished product. Our vision is a fossil-free and circular industry. Within AM4Life Swerim is active within additive manufacturing of materials for bioprocessing and implants. Swerim contributes with competence and equipment within material and process development of metals and powder. One PhD-student (Hanna Nilsson Åhman), employed at Swerim, is doing research about additive manufacturing of magnesium alloys for implants.

VBN Components are a material developing company providing customers with hard and wear resistant alloys for additive manufacturing. Vision: Renew the materials industry in the world.

Uppsala University's mission is to gain and disseminate knowledge for the benefit of humankind and for a better world.

  • The University is based on the fundamental idea and premise that investments in education and research contribute to a better future.
  • The University aims to offer an inspiring and well-functioning physical, social and cultural environment.
  • Uppsala University contributes to development and innovation locally and nationally and is an active party in the pursuit of sustainable social development.
  • Collaboration with the wider community is a natural, integral part of such research and contributes – directly or indirectly – to solutions concerning the sustainability challenges facing society.

The main scientific goal is the development of biomaterials for tissue and organs regeneration/functional repair. To address this objective, we work on design of materials which can modulate the response of the receiving tissue, leading in some cases to the regeneration and neoformation of the degraded tissues and, in others, to a perfect integration of the biomaterial and to the recovery of the lost functionality. In this multidisciplinary domain it essential to create a bridge between two differenciated fields of knowledge, such as materials science and biomedicine, with a continuous and stable interaction, based on the interdisciplinary of the members of group

Last modified: 2024-02-09